Lenvatinib as first-line therapy for recurrent hepatocellular carcinoma after liver transplantation: Is the current evidence applicable to these patients?

por Piñero, Federico, Thompson, Marcos, Marín, Juan Ignacio, Silva, Marcelo
Publicado 2020